ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction

Stock Information for Turnstone Biologics Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Turnstone Biologics Corp.

ESSA Announces Completion of Arrangement with XenoTherapeutics
ESSA Securityholders Approve Acquisition by XenoTherapeutics
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025
INVESTOR ALERT: Morris Kandinov LLP Investigating ESSA Pharma Inc. (EPIX)
Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution
Essa Pharma Inc. Announces Ex-Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash Distribution

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.